RAFLF (Raffles Medical Group) ROCE %: 9.50% (As of Dec. 2025)


RAFLF Raffles Medical Group Ltd RAFLF
57 GF Score
Price $0.75
GF Value $0.75
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Raffles Medical Group ROCE %?

Raffles Medical Group RAFLF 57 ROCE % is 9.50% as of Dec. 2025. GuruFocus rates RAFLF with a GF Score™ of 57/100 and a GF Value™ of $0.75 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Raffles Medical Group's annualized ROCE % for the quarter that ended in Dec. 2025 was 9.50%.

Raffles Medical Group  (OTCPK:RAFLF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Raffles Medical Group ROCE % Related Terms

Raffles Medical Group ROCE % Historical Data

* Premium members only.

The historical data trend for Raffles Medical Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raffles Medical Group ROCE % Chart

Raffles Medical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.70 17.33 10.91 8.02 8.90

Raffles Medical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.90 8.15 8.14 8.52 9.50
RAFLF
57GF Score
Raffles Medical Group Ltd RAFLF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raffles Medical Group ROCE % Calculation

Raffles Medical Group's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=75.687/( ( (1103.007 - 252.254) + (1107.879 - 258.45) )/ 2 )
=75.687/( (850.753+849.429)/ 2 )
=75.687/850.091
=8.90 %

Raffles Medical Group's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=80.018/( ( (1161.817 - 326.699) + (1107.879 - 258.45) )/ 2 )
=80.018/( ( 835.118 + 849.429 )/ 2 )
=80.018/842.2735
=9.50 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.50% mean?
Raffles Medical Group (RAFLF) has a ROCE % of 9.50% as of Dec. 2025.
Is Raffles Medical Group's ROCE % too high?
Raffles Medical Group's current ROCE % is 9.50%. The Healthcare Providers & Services industry median ROCE % is 6.42. Raffles Medical Group's value of 9.50% is 48% above this industry median. Overall, Raffles Medical Group has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's ROCE % compare to HCA and THC?
Raffles Medical Group's ROCE % of 9.50% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.42. Raffles Medical Group's value of 9.50% is 48% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.42, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current ROCE % of 9.50% is 48% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current ROCE % is 9.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (RAFLF) is currently considered Fairly Valued. The stock's GF Value™ is $0.75, compared to a current price of $0.75 — trading 0.4% above its estimated fair value. The current ROCE % is 9.50% and 48% above the Healthcare Providers & Services industry median of 6.42. Raffles Medical Group's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Raffles Medical Group (RAFLF), the current ROCE % is 9.50% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raffles Medical Group (RAFLF) Overvalued in 2026?

Based on GuruFocus' analysis, Raffles Medical Group stock appears to be overvalued. The current stock price of $0.75 is trading 0.4% above its estimated GF Value™ of $0.75. GuruFocus considers Raffles Medical Group to be Fairly Valued.

Key valuation signals for RAFLF:

  • ROCE %: 9.50%
  • GF Value™: $0.75 vs. price of $0.75 (0.4% above fair value)
  • GF Score™: 57/100 with 4 warning signs
  • Industry Position: 48% above the Healthcare Providers & Services median

No single metric tells the full story. See the RAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raffles Medical Group Business Description

Other Exchanges BSL:Singapore
Address 585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
57GF Score

Get the complete analysis for RAFLF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price
$0.75
GF Value